STANDARD BIOTOOLS INC. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Standard Biotools Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • Standard Biotools Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$31.7M, a 49.8% decline year-over-year.
  • Standard Biotools Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$164M, a 115% decline year-over-year.
  • Standard Biotools Inc. annual Operating Income (Loss) for 2023 was -$76.6M, a 34.1% increase from 2022.
  • Standard Biotools Inc. annual Operating Income (Loss) for 2022 was -$116M, a 72.3% decline from 2021.
  • Standard Biotools Inc. annual Operating Income (Loss) for 2021 was -$67.5M, a 32.2% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$164M -$31.7M -$10.5M -49.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 -$153M -$50.5M -$33.1M -190% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 -$120M -$60.2M -$43.6M -263% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$76.6M -$21.4M -$274K -1.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-01
Q3 2023 -$76.3M -$21.2M +$7.86M +27.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 -$84.2M -$17.4M +$21.1M +54.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 -$105M -$16.6M +$10.9M +39.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$116M -$21.1M -$9.85M -87.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-01
Q3 2022 -$106M -$29M -$9.42M -48% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$96.9M -$38.6M -$21.3M -123% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$75.6M -$27.5M -$8.18M -42.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$67.5M -$11.3M +$5.65M +33.4% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-14
Q3 2021 -$73.1M -$19.6M -$14.1M -259% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$59M -$17.3M -$3.54M -25.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$55.4M -$19.3M -$4.38M -29.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 -$51M -$16.9M -$7.72M -84.1% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-08
Q3 2020 -$43.3M -$5.46M +$8.35M +60.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$51.7M -$13.7M +$910K +6.22% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 -$52.6M -$14.9M -$736K -5.18% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 -$51.8M -$9.18M +$1.94M +17.4% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-08
Q3 2019 -$53.8M -$13.8M -$2.19M -18.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$51.6M -$14.6M -$1.85M -14.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 -$49.7M -$14.2M -$1.57M -12.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$48.2M -$11.1M -$2.38M -27.3% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 -$45.8M -$11.6M +$3.97M +25.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 -$49.8M -$12.8M +$3.7M +22.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 -$53.5M -$12.6M +$4.9M +28% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 -$58.4M -$8.74M +$8.96M +50.6% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-27
Q3 2017 -$67.3M -$15.6M +$2.88M +15.6% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 -$70.2M -$16.5M +$1.66M +9.12% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 -$71.9M -$17.5M +$1.33M +7.06% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 -$73.2M -$17.7M -$4M -29.2% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-18
Q3 2016 -$69.2M -$18.5M -$10.7M -137% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 -$58.5M -$18.1M -$3.48M -23.8% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 -$55M -$18.9M -$4.87M -34.8% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 -$50.2M -$13.7M -$3.86M -39.2% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-08
Q3 2015 -$46.3M -$7.8M +$5.24M +40.2% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$51.5M -$14.7M -$2.28M -18.4% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 -$49.3M -$14M +$2.58M +15.6% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$51.8M -$9.83M -$5.19M -112% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-03
Q3 2014 -$46.6M -$13M -$8.1M -163% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 -$38.6M -$12.4M -$8.39M -210% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 -$30.2M -$16.6M -$11.5M -227% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 -$18.7M -$4.64M -$1.15M -33% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 -$17.5M -$4.95M -$1.04M -26.7% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 -$16.5M -$3.99M +$396K +9.03% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-04
Q1 2013 -$16.9M -$5.07M +$1.22M +19.4% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 -$18.1M -$3.49M -$514K -17.3% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-26
Q3 2012 -$17.6M -$3.91M +$146K +3.6% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-07
Q2 2012 -$17.7M -$4.39M +$2.27M +34.1% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-07
Q1 2012 -$20M -$6.28M -$1.41M -28.8% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 -$18.6M -$2.98M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-12
Q3 2011 -$4.06M -$956K -30.8% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 -$6.65M -$2.43M -57.5% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 -$4.88M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q3 2010 -$3.1M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$4.23M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.